RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 1 filers reported holding RELMADA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,130 | -56.7% | 1,710 | -64.5% | 0.00% | – |
| Q2 2023 | $11,850 | +118400.0% | 4,817 | +4.3% | 0.00% | – |
| Q1 2023 | $10 | -88.1% | 4,619 | -80.8% | 0.00% | -100.0% |
| Q4 2022 | $84 | -99.7% | 24,041 | +2721.7% | 0.00% | +200.0% |
| Q3 2022 | $32,000 | +14.3% | 852 | -42.0% | 0.00% | 0.0% |
| Q2 2022 | $28,000 | +366.7% | 1,469 | +606.2% | 0.00% | – |
| Q1 2022 | $6,000 | -78.6% | 208 | -83.0% | 0.00% | – |
| Q4 2021 | $28,000 | +55.6% | 1,227 | +80.2% | 0.00% | – |
| Q3 2021 | $18,000 | -45.5% | 681 | -34.6% | 0.00% | -100.0% |
| Q2 2021 | $33,000 | -47.6% | 1,041 | -42.1% | 0.00% | 0.0% |
| Q1 2021 | $63,000 | +70.3% | 1,798 | +52.6% | 0.00% | 0.0% |
| Q4 2020 | $37,000 | -92.0% | 1,178 | -90.4% | 0.00% | -80.0% |
| Q3 2020 | $462,000 | +1055.0% | 12,282 | +1263.2% | 0.01% | +150.0% |
| Q2 2020 | $40,000 | -52.4% | 901 | -58.0% | 0.00% | -71.4% |
| Q4 2019 | $84,000 | – | 2,143 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 668,440 | $25,147,000 | 4.92% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,810,000 | 3.40% |
| ACUTA CAPITAL PARTNERS, LLC | 277,000 | $10,421,000 | 2.83% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 455,137 | $17,122,000 | 1.67% |
| RTW INVESTMENTS, LP | 1,511,337 | $56,857,000 | 1.37% |
| Avoro Capital Advisors LLC | 1,500,000 | $56,430,000 | 0.80% |
| Pegasus Asset Management, Inc. | 26,958 | $1,014,000 | 0.64% |
| RA Capital Management | 781,290 | $29,392,000 | 0.54% |
| TIEDEMANN ADVISORS, LLC | 269,839 | $10,151,000 | 0.49% |
| Boxer Capital, LLC | 300,000 | $11,286,000 | 0.39% |